Bausch Health Companies | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Amgen USD 5.54B 430M 2025-03
ANI Pharmaceuticals USD 110.29M 134.46M 2024-12
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Bausch Health Companies USD 1.56B 274M 2025-03
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 154.81M 24.12M 2025-03
Danaher USD 3.53B 364M 2025-03
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
Novo Nordisk 65.2B 5.19B 2025-03
Pacira USD 134.62M 12.75M 2025-03
Perrigo USD 385.9M 18.5M 2024-12
Prestige Brands USD 170.01M 8.96M 2025-03
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Zoetis USD 1.6B 12M 2025-03



Bausch Health Companies Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.